# FDA Inspection 1290266 - Dr. Dwarkesh Oswal, M.D. - October 16, 2025

Source: https://www.keypedia.com/records/fda_inspections/dr-dwarkesh-oswal-md/13c478b6-158f-4e11-ad1f-14a86b8240f8
Source feed: FDA_Inspections

> FDA Inspection 1290266 for Dr. Dwarkesh Oswal, M.D. on October 16, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1290266
- Company Name: Dr. Dwarkesh Oswal, M.D.
- Inspection Date: 2025-10-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1290266 - 2025-10-16](https://www.keypedia.com/records/fda_inspections/dr-dwarkesh-oswal-md/29e6cbd3-6820-4fc9-982f-cf6e16a1c25a)

Company: https://www.keypedia.com/companies/dr-dwarkesh-oswal-md/4f0ce8e2-6ea9-4d13-bb05-003b94a95d57

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
